Endogenous isobaric interference on serum 17 hydroxyprogesterone by liquid chromatography-tandem mass spectrometry methods

Affiliations

¹ Biomedical Mass Spectrometry Unit, Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT, Hong Kong.
² Department of Clinical Biochemistry, PathWest Laboratory Medicine, Fiona Stanley Hospital, Murdoch, Western Australia.
³ Department of Laboratory Medicine, National University Hospital, Singapore.
⁴ Department of Clinical Chemistry and Department of Internal Medicine, Erasmus University Medical Centre, Rotterdam, The Netherlands.
⁵ Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, VIC, Australia.
⁶ Steroid Research & Mass Spectrometry Unit of the Laboratory for Translational Hormone Analytics in Pediatric Endocrinology at the Justus Liebig University, Giessen, Germany.

Clara Wai Shan Lo et al. Clin Chem Lab Med. 2022.

. 2022 Dec 2;61(3):e64-e66.

doi: 10.1515/cclm-2022-1086. Print 2023 Feb 23.

¹ Biomedical Mass Spectrometry Unit, Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT, Hong Kong.
² Department of Clinical Biochemistry, PathWest Laboratory Medicine, Fiona Stanley Hospital, Murdoch, Western Australia.
³ Department of Laboratory Medicine, National University Hospital, Singapore.
⁴ Department of Clinical Chemistry and Department of Internal Medicine, Erasmus University Medical Centre, Rotterdam, The Netherlands.
⁵ Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, VIC, Australia.
⁶ Steroid Research & Mass Spectrometry Unit of the Laboratory for Translational Hormone Analytics in Pediatric Endocrinology at the Justus Liebig University, Giessen, Germany.

No abstract available

Keywords: 17-hydroxyprogesterone; congenital adrenal hyperplasia (CAH); endogenous interference.

References

1. Honour, JW. 17-Hydroxyprogesterone in children, adolescents and adults. Ann Clin Biochem 2014;51:424–40. https://doi.org/10.1177/0004563214529748 . - DOI
1. de Hora, MR, Heather, NL, Patel, T, Bresnahan, LG, Webster, D, Hofman, PL. Measurement of 17-hydroxyprogesterone by LCMSMS improves newborn screening for CAH due to 21-hydroxylase deficiency in New Zealand. Int J Neonatal Screen 2020;6:6. https://doi.org/10.3390/ijns6010006 . - DOI
1. Long, Q, Zhang, T, Yan, Y, Zhao, H, Zhou, W, Zeng, J, et al.. Measurement of serum 17-hydroxyprogesterone using isotope dilution liquid chromatography-tandem mass spectrometry candidate reference method and evaluation of the performance for three routine methods. Clin Chem Lab Med 2021;59:523–32. https://doi.org/10.1515/cclm-2020-0410 . - DOI
1. Fiet, J, Gueux, B, Raux-DeMay, MC, Kuttenn, F, Vexiau, P, Brerault, JL, et al.. Increased plasma 21-deoxycorticosterone (21-DB) levels in late-onset adrenal 21-hydroxylase deficiency suggest a mild defect of the mineralocorticoid pathway. J Clin Endocrinol Metab 1989;68:542–7. https://doi.org/10.1210/jcem-68-3-542 . - DOI
1. Villee, DB, Dimoline, A, Engel, LL, Villee, CA, Raker, J. Formation of 16a-hydroxyprogesterone in hyperplastic adrenal tissue. J Clin Endocrinol Metab 1962;22:726–34. https://doi.org/10.1210/jcem-22-7-726 . - DOI